LifeStance Health Group, Inc. — Form 8-K Summary
Business context and reporting period
LifeStance Health Group, Inc. filed a Form 8-K dated March 12, 2024, under Item 5.02 regarding a change to its board of directors. The filing does not report quarterly or annual financial results.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Material change
Effective immediately on March 12, 2024, the Board appointed Teresa DeLuca as a director of the Company.
Guidance, outlook, risks, and unusual items
The filing provides no management outlook, guidance, risk update, contingency disclosure, compensation details, or other unusual items related to the appointment.
Important facts to verify
- Confirm Teresa DeLuca’s responsibilities, committee assignments, independence status, and relevant qualifications in subsequent filings or company disclosures.
- Review any subsequent disclosure regarding director compensation or related-party transactions.
- Note that this filing contains no clear value for operating or financial performance.